Lee lab at Johns Hopkins School of Medicine
The Lee group at the Johns Hopkins School of Medicine utilizes human pluripotent stem cells and reprogramming technology to unravel cell fate specification processes, relevant to human diseases of neural and skeletal muscle system.
The Lee group at the Johns Hopkins School of Medicine utilizes human pluripotent stem cells and reprogramming technology to unravel cell fate specification processes, relevant to human diseases of neural and skeletal muscle system.
Current and previous funding sources:
NSF, NIH, The New York Stem Cell Foundation, Maryland Stem Cell Research Fund, The Scleroderma Research Foundation, National Research Foundation (Korea), The Blaustein Pain Research Foundation, The FSH Society, The CMT Association, Muscular Dystrophy Association, Yuyan DNU, Research Foundation in Korea, The Helis Foundation, The Singh Family Foundation, The Packard ALS Center, Mirowski Discovery Fund, Johns Hopkins School of Medicine, Vita Therapeutics, Stealth Biotherapeutics, Cocoon INC, The Neurofibromatosis Therapeutic Acceleration Program, The Gilbert Family Foundation, Life Technologies, New York State Funding for Stem Cell Research, Private donors